This article was originally published in The Gray Sheet
Diagnostics manufacturer and group purchasing organization sign four 21-month supply agreements expected to result in a combined $173 mil. in sales. Among devices included in the agreements are the Access 2 immunoassay system, COULTER LH 700 series hematology analyzers and ACL brand coagulation analyzers. In addition to the two contracts for chemistry and immunodiagnostic instrments, test kits and supplies, the deals also renew two contracts for hematology and coagulation products...
You may also be interested in...
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.
The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval.
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.